Pioglitazone And Metformin Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: Pioglitazone 15/30 mg + Metformin 500/850/1000 mg
Reference Brands: Actoplus Met (USA), Competact (EU)
Category: Diabetes
Pioglitazone enhances insulin sensitivity in muscle and adipose tissue by activating PPAR-γ receptors, while Metformin reduces hepatic glucose production and improves peripheral glucose uptake. This synergistic combination effectively lowers blood glucose levels in type 2 diabetes, enhances glycemic control, and may support weight neutrality with improved insulin responsiveness.
Product Description:
Pioglitazone + Metformin tablets are approved in the EU and selectively in the USA as combination therapy for type 2 diabetes mellitus when diet, exercise, and monotherapy are insufficient. In the EU, these are regulated under the EMA and marketed under various brand names, while in the US, FDA approval varies by formulation. The combination offers dual benefits: Pioglitazone improves insulin sensitivity, while Metformin decreases hepatic glucose production. Regulatory agencies emphasize cardiovascular risk assessment and liver monitoring. Pharmatradz.com connects global B2B pharmaceutical buyers and sellers for Pioglitazone + Metformin tablets across regulated and semi-regulated markets efficiently and reliably.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Pioglitazone and Metformin is used to improve glycemic control in adults with type 2 diabetes mellitus. Pioglitazone increases insulin sensitivity in peripheral tissues, while Metformin decreases hepatic glucose production and improves insulin action, making the combination effective for lowering blood glucose levels when diet, exercise, or monotherapy are insufficient.
This combination contains pioglitazone hydrochloride, a thiazolidinedione that enhances insulin sensitivity, and metformin hydrochloride, a biguanide that reduces glucose production in the liver and improves insulin-mediated glucose uptake.
The combination is marketed under brand names such as Actoplus Met and Competact in various regions.
It is manufactured by multiple pharmaceutical companies globally, including generic and branded manufacturers approved in different countries.
The generic name is pioglitazone and metformin.
Common brand names include Actoplus Met and Competact.
Pioglitazone and Metformin is manufactured in several countries, including India, the USA, and European nations, by approved pharmaceutical manufacturers.
Related Products
Pioglitazone Hydrochloride 150Mg Tablet
Strength:
15 mg, 30 mg, 45 mg
Form: Tablets
Reference Brands: Actos (USA)
View Details
Nateglinide
Strength:
60 mg, 120 mg, 180 mg
Form: Tablets
Reference Brands: Starlix (USA)
View Details
Miglitol
Strength:
25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Glyset (USA), Diastabol (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
